Alyeska Investment Group
ZYME icon

Alyeska Investment Group’s Zymeworks ZYME Stock Holding History

Alyeska Investment Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,502,720
Closed -$9.24M – 526
2022
Q3 		$9.24M Buy
1,502,720
+111,975
+8% +$675K 0.11% 214
2022
Q2 		$7.37M Buy
1,390,745
+226,642
+19% +$1.37M 0.08% 248
2022
Q1 		$7.63M Buy
1,164,103
+493,763
+74% +$4.4M 0.08% 240
2021
Q4 		$11M Buy
670,340
+374,417
+127% +$7.81M 0.13% 184
2021
Q3 		$8.59M Buy
295,923
+72,103
+32% +$2.4M 0.11% 222
2021
Q2 		$7.76M Sell
223,820
-63,445
-22% -$2.01M 0.09% 256
2021
Q1 		$9.07M Buy
287,265
+89,052
+45% +$3.62M 0.12% 213
2020
Q4 		$9.37M Sell
198,213
-172,649
-47% -$8.02M 0.13% 205
2020
Q3 		$17.3M Buy
370,862
+135,300
+57% +$4.65M 0.26% 123
2020
Q2 		$8.5M Buy
235,562
+8,191
+4% +$302K 0.13% 220
2020
Q1 		$8.06M Buy
+227,371
New +$9.31M 0.16% 147
2019
Q3 		– Sell
-242,869
Closed -$5.34M – 515
2019
Q2 		$5.34M Buy
+242,869
New +$4.46M 0.07% 220
2018
Q3 		– Sell
-450,000
Closed -$6.65M – 523
2018
Q2 		$6.65M Buy
450,000
+294,461
+189% +$4.56M 0.06% 253
2018
Q1 		$1.87M Sell
155,539
-18,387
-11% -$199K 0.02% 350
2017
Q4 		$1.32M Hold
173,926
– – 0.01% 369
2017
Q3 		$1.39M Buy
173,926
+3,105
+2% +$24.1K 0.01% 399
2017
Q2 		$1.43M Buy
+170,821
New +$1.91M 0.01% 374

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Alyeska Investment Group's ZYME Position: Q4 2022 in Review

Alyeska Investment Group sold out of Zymeworks (ZYME) in Q4 2022, closing a stake of 1,502,720 shares — an estimated $9.24M sold.

Alyeska Investment Group first reported a position in ZYME in Q2 2017 and held it in 17 quarters. The position peaked at $17.3M in Q3 2020. 96 funds tracked by Wall St. Rank hold ZYME as of Q4 2022.

  • Alyeska Investment Group reported no remaining Zymeworks position as of Q4 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 1,502,720 Zymeworks shares in Q4 2022, an estimated $9.24M.
  • Alyeska Investment Group first reported a position in Zymeworks in Q2 2017 and held it in 17 quarters.
  • Alyeska Investment Group's Zymeworks position peaked at $17.3M in Q3 2020.
  • 96 funds tracked by Wall St. Rank held Zymeworks as of Q4 2022.

Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.